In addition, cytokine-activated NK cells with upregulated NCRs and NKG2D are partly able to overcome tumor immune escape by restoring NKG2D-mediated NK cell cytotoxicity via scavenging of plasma MICA as demonstrated for neuroblastoma and head and neck cancer, respectively (124, 132). This evidence concerns the gene KLRK1 and head and neck cancer.